Exact Mass: 363.2443

Exact Mass Matches: 363.2443

Found 33 metabolites which its exact mass value is equals to given mass value 363.2443, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cardiopetalidine

Cardiopetalidine

C21H33NO4 (363.2409)


   

Cetrimonium Bromide

Hexadecyl trimethyl ammonium bromide

C19H42N. Br (363.25)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent C254 - Anti-Infective Agent > C52588 - Antibacterial Agent D000890 - Anti-Infective Agents Same as: D03454

   

Talinolol

N-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N-cyclohexylcarbamimidic acid

C20H33N3O3 (363.2522)


Talinolol belongs to the family of Alkyl Aryl Ethers. These are organic compounds containing the alkyl aryl ether functional group with formula R-O-R , where R is an alkyl group and R is an aryl group. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

N-Palmitoyltaurine

2-[(1-Oxohexadecyl)amino]ethanesulfonic acid

C18H37NO4S (363.2443)


N-Palmitoyltaurine, also known as N-hexadecanoyltaurine, belongs to the class of organic compounds known as N-acyl amines. N-Acyl amines are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. Thus, N-palmitoyltaurine is considered to be a fatty amide lipid molecule. N-Palmitoyltaurine is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Specifically, N-palmitoyltaurine belongs to the N-acyl taurines (NATs) fatty acid amide class. NATs with chains ranging in length from C16 to C24 have been identified in mice brain, liver, and kidney tissues. NATs were found to be regulated by the integral membrane enzyme fatty acid amide hydrolase (FAAH) and activated calcium channels from the transient receptor potential (TRP) family such as TRPV1 and TRPV4 (PMID: 16866345).

   

N-Lauroyl Tyrosine

2-[(1-Hydroxydodecylidene)amino]-3-(4-hydroxyphenyl)propanoate

C21H33NO4 (363.2409)


N-lauroyl tyrosine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Tyrosine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Tyrosine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Tyrosine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

16beta-Hydroxycardiopetaline

16beta-Hydroxycardiopetaline

C21H33NO4 (363.2409)


   

N-Palmitoyl Taurine

N-hexadecanoyl-taurine

C18H37NO4S (363.2443)


   

Oxime-Isodigipurpurogenin II

Oxime-Isodigipurpurogenin II

C21H33NO4 (363.2409)


   

8-O-Acetylhyeronimone

8-O-Acetylhyeronimone

C21H33NO4 (363.2409)


   

SCHEMBL15121449

SCHEMBL15121449

C21H33NO4 (363.2409)


   

Talinolol

N-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N-cyclohexylcarbamimidic acid

C20H33N3O3 (363.2522)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

NAT 16:0

N-hexadecanoyl-taurine

C18H37NO4S (363.2443)


   

2-dihexoxyphosphoryl-N,N-diethylacetamide

2-dihexoxyphosphoryl-N,N-diethylacetamide

C18H38NO4P (363.2538)


   

(R)-TERT-BUTYL 4-(4-(BENZYLOXY)BUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

(R)-TERT-BUTYL 4-(4-(BENZYLOXY)BUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

C21H33NO4 (363.2409)


   

2-(((tert-Butyldimethylsilyl)oxy)methyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

2-(((tert-Butyldimethylsilyl)oxy)methyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

C19H34BNO3Si (363.2401)


   

N-Dodecanoyl-L-Tyrosine

N-Dodecanoyl-L-Tyrosine

C21H33NO4 (363.2409)


   

Cetrimonium Bromide

Hexadecyl trimethyl ammonium bromide

C19H42BrN (363.25)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent C254 - Anti-Infective Agent > C52588 - Antibacterial Agent D000890 - Anti-Infective Agents

   

N-Hexadecanoyltaurine

N-Hexadecanoyltaurine

C18H37NO4S (363.2443)


A fatty acid-taurine conjugate derived from hexadecanoic acid.

   

SPHP(18:1)

SPHP(m18:1)

C18H38NO4P (363.2538)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-His 14:1(9Z)

NA-His 14:1(9Z)

C20H33N3O3 (363.2522)


   

NA-Ser 18:4(6Z,9Z,12Z,15Z)

NA-Ser 18:4(6Z,9Z,12Z,15Z)

C21H33NO4 (363.2409)


   

NA-Taurine 16:0

NA-Taurine 16:0

C18H37NO4S (363.2443)


   
   

ST 19:1;O2;Gly

ST 19:1;O2;Gly

C21H33NO4 (363.2409)


   

2,6-dimethyl-8-oxo-8-({2,4,7-trimethyl-octahydrocyclopenta[c]pyridin-6-yl}oxy)octa-2,6-dienoic acid

2,6-dimethyl-8-oxo-8-({2,4,7-trimethyl-octahydrocyclopenta[c]pyridin-6-yl}oxy)octa-2,6-dienoic acid

C21H33NO4 (363.2409)


   

n-(4-hydroxy-2-{[(10-methylundecyl)oxy]carbonyl}phenyl)ethanimidic acid

n-(4-hydroxy-2-{[(10-methylundecyl)oxy]carbonyl}phenyl)ethanimidic acid

C21H33NO4 (363.2409)


   

16β-hydroxycardiopetaline

NA

C21H33NO4 (363.2409)


{"Ingredient_id": "HBIN001831","Ingredient_name": "16\u03b2-hydroxycardiopetaline","Alias": "NA","Ingredient_formula": "C21H33NO4","Ingredient_Smile": "CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9894","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1s,2s,3s,4s,5s,6r,8r,9s,10r,13r,16r,17r)-11-ethyl-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,6,8,16-tetrol

(1s,2s,3s,4s,5s,6r,8r,9s,10r,13r,16r,17r)-11-ethyl-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,6,8,16-tetrol

C21H33NO4 (363.2409)


   

(1s,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,6,8,16-tetrol

(1s,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,6,8,16-tetrol

C21H33NO4 (363.2409)


   

n-{2-[(dodecyloxy)carbonyl]-4-hydroxyphenyl}ethanimidic acid

n-{2-[(dodecyloxy)carbonyl]-4-hydroxyphenyl}ethanimidic acid

C21H33NO4 (363.2409)


   

11-ethyl-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,6,8,16-tetrol

11-ethyl-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,6,8,16-tetrol

C21H33NO4 (363.2409)


   

(2e,6e)-8-{[(4s,4ar,6s,7r,7as)-2,4,7-trimethyl-octahydrocyclopenta[c]pyridin-6-yl]oxy}-2,6-dimethyl-8-oxoocta-2,6-dienoic acid

(2e,6e)-8-{[(4s,4ar,6s,7r,7as)-2,4,7-trimethyl-octahydrocyclopenta[c]pyridin-6-yl]oxy}-2,6-dimethyl-8-oxoocta-2,6-dienoic acid

C21H33NO4 (363.2409)